Relative valuation already teaches you how much control typically costs. That's the empirical premium precedent transactions pay over an unaffected trading price, bounded by standalone value plus control value plus synergies, and distorted upward by auction dynamics (the winner's curse). The advisory seat asks an earlier question, one a pricing model can't answer. Given the price being paid for control, does the deal's actual legal structure deliver the specific decision rights the synergy ledger assumes? And will the buyer actually be able to exercise them?
What is the control spectrum, and why does control have value?
The control spectrum. Ownership and control are different variables, and a deal can end up anywhere on a spectrum between them. At one end is a passive minority stake, with no influence. Next comes a minority stake with a board seat and information rights, which buys influence but no control. Then joint control, meaning a joint venture or consortium with shared veto rights over "reserved matters." After that comes majority control subject to minority protections. In India, the Companies Act 2013 requires a 75% special resolution for a defined set of major actions. Many negotiated deals also leave the seller a meaningful minority stake with contractual veto rights over the very actions a synergy case needs. At the far end is full, unencumbered control (100% ownership, no minority overhang, no contractual carve-outs).
Why control has value beyond the pro-rata cash flow. A passive holder of cash-flow rights can't force a plant closed, can't redirect capital allocation, can't replace management, can't redirect dividend policy, and can't combine the target's assets with anything else. Control is the right to compel the actions most of the cost-synergy ledger depends on. So a synergy case and a control question are really one question asked twice.
Advertisement
Why can a majority stake still lack control?
The trap: control on paper, not in practice. A buyer can hold a nominal majority and still lack the practical ability to execute the plan the ledger assumes. There are several concrete reasons, and each is worth checking line by line against the deal's actual shareholders' agreement (SHA) or scheme documents. The first is reserved-matter veto rights granted to a rolled-over founder or minority seller, commonly covering facility closures, headcount actions above a stated threshold, or executive removal. Next is an earn-out or seller-rollover-equity structure. That keeps the seller economically entangled with the very cost actions the case needs, and so practically resistant to them. A multi-year employment guarantee for the founder as managing director can come with board-approval rights over restructuring baked into the SHA. Statutory consultation requirements (works-council-style regimes in several jurisdictions) can slow or block a unilateral headcount action. And sector-specific foreign-ownership or regulatory caps can formally limit "control" below the economic stake actually held.
How do you test a synergy case against the control terms?
The advisory move. Take every line in the synergy ledger that requires a unilateral action, such as closing a facility, cutting headcount above a threshold, or replacing a leader. Check it against the deal's actual governance terms. Where a veto, an employment guarantee, or a regulatory cap constrains the buyer's practical authority to execute, risk-weight that specific line down or zero it out for the period the constraint holds. The cap table's headline ownership percentage won't tell you this. The worked example on a majority stake without control walks through the test with real numbers. It shows how a majority stake can still leave the largest single line in a synergy ledger unexecutable for years.
{
"skill": "Drafting a first-pass governance/control checklist against a term sheet or shareholders' agreement before signing off on a synergy case",
"use": "Have an AI assistant read a term sheet or SHA summary and flag every clause that could constrain the buyer's practical ability to execute a stated synergy action (reserved matters, employment guarantees, earn-outs, consultation rights, ownership caps) as a checklist for you to verify against the actual document.",
"tools": ["Document/PDF AI — run over the actual term sheet or SHA you hold", "Chat assistants — Claude, ChatGPT, for drafting the checklist structure"],
"prompt": "Read this term sheet / shareholders' agreement summary. List every clause that could limit the buyer's practical (not just economic) control over: (1) closing a facility, (2) reducing headcount above a stated threshold, (3) replacing the target's senior management, (4) redirecting capital allocation or dividend policy. For each, state which synergy-ledger line it could block or delay and for how long.",
"verify": "Treat the AI's clause list as a first pass to check against the actual signed document, never as the final legal read — a materially wrong reading of a veto right could sink or waste an entire deal. Have counsel confirm every clause the model flags as material, and re-read the primary document yourself line by line before risk-weighting any synergy line down (Guardrail: Trace to the actual document, Match its exact wording, never accept a paraphrase as the source).",
"diy": "You must already understand the control spectrum and be able to name, unaided, which kinds of synergy actions require unilateral authority — that is this section's job. AI accelerates the first read of a long document; it does not replace the judgment of which clause actually matters to which ledger line.",
"market": "US"
}